Divi's Laboratories Ltd.

NSE: DIVISLAB | BSE: 532488 | ISIN: INE361B01024 | Industry: Pharmaceuticals
| Expensive Star
6483.0000 -55.00 (-0.84%)
NSE May 23, 2025 15:31 PM
Volume: 224.1K
 

6483.00
-0.84%
Phillip Capital
finetuned our FY16/FY17 EPS estimates to Rs 77.8/92.4, 2.9%/2.4% higher than before. We now value the company at Rs 1,940, 21x FY17 EPS, vs. Rs 1,900 earlier. Due to the limited upside potential (5%), we retain our NEUTRAL rating. The company's 80%+...
Divi's Laboratories .. has an average target of 5832.12 from 9 brokers.
More from Divi's Laboratories Ltd.
Recommended